BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Teva
Dow
Novartis
Federal Trade Commission
US Department of Justice
Chinese Patent Office
Covington
Accenture

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,537,586

« Back to Dashboard

Which drugs does patent 6,537,586 protect, and when does it expire?

Patent 6,537,586 protects VIVITROL and is included in one NDA.

This patent has twenty patent family members in ten countries.
Summary for Patent: 6,537,586
Title: Apparatus and method for preparing microparticles
Abstract:Apparatus and method for preparing microparticles. An emulsion is formed by combining two phases in a static mixing assembly. The static mixing assembly preferably includes a preblending static mixer and a manifold. The emulsion flows out of the static mixing assembly into a quench liquid whereby droplets of the emulsion form microparticles. The residence time of the emulsion in the static mixing assembly is controlled to obtain a predetermined particle size distribution of the resulting microparticles.
Inventor(s): Lyons; Shawn L. (Cincinnati, OH), Wright; Steven G. (Madeira, OH)
Assignee: Alkermes Controlled Therapeutics Inc. II (Cambridge, MA)
Application Number:10/109,641
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 6,537,586

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Alkermes VIVITROL naltrexone FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 021897-001 Apr 13, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,537,586

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,705,757 Method and apparatus for preparing microparticles using in-line solvent extraction ➤ Subscribe
6,331,317 Apparatus and method for preparing microparticles ➤ Subscribe
6,939,033 Method and apparatus for preparing microparticles using in-line solvent extraction ➤ Subscribe
6,395,304 Apparatus and method for preparing microparticles ➤ Subscribe
6,713,090 Apparatus and method for preparing microparticles ➤ Subscribe
6,540,393 Apparatus for preparing microparticles using in-line solvent extraction ➤ Subscribe
6,495,166 Apparatus and method for preparing microparticles using in-line solvent extraction ➤ Subscribe
7,510,730 Apparatus and method for preparing microparticles using in-line solvent extraction ➤ Subscribe
6,861,016 Apparatus and method for preparing microparticles ➤ Subscribe
7,300,671 Method and apparatus for preparing microparticles using in-line solvent extraction ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,537,586

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 286722 ➤ Subscribe
Austria 349201 ➤ Subscribe
Australia 2750801 ➤ Subscribe
Australia 3437901 ➤ Subscribe
Australia 771497 ➤ Subscribe
Australia 773734 ➤ Subscribe
Canada 2390284 ➤ Subscribe
Canada 2390563 ➤ Subscribe
Germany 60017461 ➤ Subscribe
Germany 60032631 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Covington
Dow
Healthtrust
Merck
Teva
US Army
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot